Ixekizumab (Anti-CTLA-8 / IL-17a)Ixekizumab (Anti-CTLA-8 / IL-17a)
Move your mouse over image or click to enlarge

Ixekizumab (Anti-CTLA-8 / IL-17a)

Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.
Cat# Size Price Qty Buy
A2862-1mg*25 1mg*25
£2,432.00
A2862-1mg*5 1mg*5
£794.00
A2862-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2862

Related Documents